Docebo (DCBO) Liabilities and Shareholders Equity (2019 - 2026)

Docebo has reported Liabilities and Shareholders Equity for 8 years, with the latest figure at $253.6 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 28.27% year-over-year to $253.6 million; the trailing twelve-month figure through Mar 2026 stood at $804.7 million (up 9.29% YoY), and the FY2025 full-year result was $206.6 million, up 8.35% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $253.6 million, up from $206.6 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $295.2 million in Q1 2023, with the low at $158.4 million in Q4 2023.
• Historically, Liabilities and Shareholders Equity has averaged $224.1 million across 5 years, with a median of $206.6 million in 2025.
• Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity tumbled 44.17% — and 2026, when it grew 28.27%.
• Docebo's Liabilities and Shareholders Equity stood at $283.7 million in 2022, then plunged by 44.17% to $158.4 million in 2023, then grew by 20.42% to $190.7 million in 2024, then grew by 8.35% to $206.6 million in 2025, then gained by 22.7% to $253.6 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $253.6 million (Q1 2026), $206.6 million (Q4 2025), and $173.2 million (Q3 2025), per Business Quant data.